Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/30/01 | Optional form for registration of securities to be sold to the public by small business issuers |
|
32 | ||
| 02/07/01 | Optional form for registration of securities to be sold to the public by small business issuers |
|
47 |